from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3623/lpqG

LFCtreatmentdescriptionclass of inhibitor

0.453

Amikacinug/mL Amikacintranslation

0.855

Cap5-10ug/mL Capreomycintranslation

-0.704

Rox10-50 ug/mL Roxithromycintranslation

0.634

SM2-5 ug/mL Streptomycintranslation

1.205

Tet5-10 ug/mL Tetracyclinetranslation

0.501

Rif0.2-5ug/mL Rifampicintranscription

-0.040

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.253

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.765

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.986

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.653

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.566

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.717

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.898

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.692

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.801

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.372

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.373

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.438

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.269

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-2.415

KCN5-20 ug/mL Potassium cyaniderespiration

-0.886

NaN30.2-2 mM Sodium aziderespiration

0.543

Nigericin50 uM Nigericinrespiration

-0.583

TRC10-150 ug/mL Triclosanrespiration

-1.100

TRZ10-25 ug/mL Thioridazinerespiration

0.522

Valinomycin0.5-10 uM Valinomycinrespiration

0.476

ZnSO42 mM ZnSO4respiration

-0.438

menadione6-10 ug/mL Menadionerespiration

-0.252

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.890

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.044

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

1.092

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.753

NRP_1Non-replicating persistence stage 1dosRassociated

1.094

Amp0.2mg/mL AmpicillincellWall

1.017

Cephalexin20-100 ug/mL CephalexincellWall

0.751

Cerulenin0.32-5 ug/mL CerulenincellWall

1.052

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.536

EMB10-20 ug/mL EthambutolcellWall

0.888

Eta12-40 ug/mL EthionamidecellWall

0.906

INH0.2-0.4 ug/mL IsoniazidcellWall

0.123

TLM0.1-0.2 mg/mL ThiolactomycincellWall

1.202

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.720

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.174

BZA0.12 mg/mL BenzamidearomaticAmides

-0.045

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.345

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.489

H2O24 mM hydrogen peroxideDNAdamaging

0.339

Levo10 ug/mL LevofloxacinDNAdamaging

-0.127

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.485

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.457

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.159

UVUV-irradiationDNAdamaging

-0.968

ARP41-4 ug/mL Antitubercular compound ARP4?

0.208

Antimycin12.5-50 ug/mL Antimycin A?

1.445

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.068

PA_110-50 ug/mL Antitubercular compound PA-1?

0.053

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.011

PA8240.2-2 ug/mL PA-824?

-0.060

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.267

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.560

Verapamil50 uM Verapamil?

0.782

mercaptoethanol2 mM 2-Mercaptoethanol?

1.059

methoxatin10-20 ug/mL Methoxatin?